ALT Q1 2017 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$331M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$804,071-20.0% YoY

Gross Profit

-$2M-246.5% margin

Operating Income

-$3M-395.9% margin

Net Income

-$2M-273.3% margin

EPS (Diluted)

$-9.53

QoQ Revenue Growth

-28.2%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$66,180

Balance Sheet

Total Assets

$21M

Total Liabilities

$3M

Stockholders' Equity

$18M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$804,071	$1M	-20.0%
Gross Profit	-$2M	-$56,924	-3381.9%
Operating Income	-$3M	-$1M	-153.8%
Net Income	-$2M	-$1M	-79.1%